Olga Dobato Portoles , Daniel Aparicio Lopez , Reyes Ibañez Carreras , Elena Aguirre Ortega , Beatriz Eizaguirre Zarza , Carmen García Mur , Aurora Carrasquer Puyal , María Pilar Cebollero Benito , Laura Isabel Comín Novella , Marta Allue Cabañuz , Fernando Martinez Ubieto , Ramón Sousa Domínguez , Javier Torcal Aznar , Carmen Casamayor Franco
{"title":"Cáncer de mama en el varón: estudio multicéntrico en Aragón durante 27 años","authors":"Olga Dobato Portoles , Daniel Aparicio Lopez , Reyes Ibañez Carreras , Elena Aguirre Ortega , Beatriz Eizaguirre Zarza , Carmen García Mur , Aurora Carrasquer Puyal , María Pilar Cebollero Benito , Laura Isabel Comín Novella , Marta Allue Cabañuz , Fernando Martinez Ubieto , Ramón Sousa Domínguez , Javier Torcal Aznar , Carmen Casamayor Franco","doi":"10.1016/j.ciresp.2024.07.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Male breast cancer accounts for 1% of all breast cancers. Its low frequency leads to a lack of awareness, resulting in significant diagnostic delays. Additionally, this limits the available evidence, which primarily uses diagnostic-therapeutic algorithms based on women.</div></div><div><h3>Methods</h3><div>A multicenter, observational, descriptive, retrospective study was conducted in the autonomous community of Aragon, Spain, from 1995 to 2022 including men with a pathological diagnosis of breast cancer. The prevalence, clinical presentation, pathological characteristics and prognosis of this pathology in men were analyzed.</div></div><div><h3>Results</h3><div>A total of 148 patients were included, one of the largest series available, with a prevalence of 1%. The most common clinical presentation was a palpable retroareolar mass. Invasive ductal carcinoma was the most frequent type (88.89%), and luminal B was the predominant subtype (47.76%). Surgery was the most utilized treatment; mastectomy was performed in 90.34% and AL in 46.89%. At diagnosis, 52.46% had extramammary involvement. The recurrence rate was 24.1%, and the mortality attributed to the disease was 14.6%.</div></div><div><h3>Conclusions</h3><div>There is a high rate of metastatic involvement at diagnosis, a high percentage of mutilating surgeries, and a high number of recurrences compared to available studies on males. Additionally, a worse prognosis is observed compared to breast cancer in women, despite these tumors having a less aggressive molecular subtype. These findings highlight the importance of conducting studies focused on men to develop specific protocols.</div></div>","PeriodicalId":50690,"journal":{"name":"Cirugia Espanola","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Espanola","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009739X24001969","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Male breast cancer accounts for 1% of all breast cancers. Its low frequency leads to a lack of awareness, resulting in significant diagnostic delays. Additionally, this limits the available evidence, which primarily uses diagnostic-therapeutic algorithms based on women.
Methods
A multicenter, observational, descriptive, retrospective study was conducted in the autonomous community of Aragon, Spain, from 1995 to 2022 including men with a pathological diagnosis of breast cancer. The prevalence, clinical presentation, pathological characteristics and prognosis of this pathology in men were analyzed.
Results
A total of 148 patients were included, one of the largest series available, with a prevalence of 1%. The most common clinical presentation was a palpable retroareolar mass. Invasive ductal carcinoma was the most frequent type (88.89%), and luminal B was the predominant subtype (47.76%). Surgery was the most utilized treatment; mastectomy was performed in 90.34% and AL in 46.89%. At diagnosis, 52.46% had extramammary involvement. The recurrence rate was 24.1%, and the mortality attributed to the disease was 14.6%.
Conclusions
There is a high rate of metastatic involvement at diagnosis, a high percentage of mutilating surgeries, and a high number of recurrences compared to available studies on males. Additionally, a worse prognosis is observed compared to breast cancer in women, despite these tumors having a less aggressive molecular subtype. These findings highlight the importance of conducting studies focused on men to develop specific protocols.
期刊介绍:
Cirugía Española, an official body of the Asociación Española de Cirujanos (Spanish Association of Surgeons), will consider original articles, reviews, editorials, special articles, scientific letters, letters to the editor, and medical images for publication; all of these will be submitted to an anonymous external peer review process. There is also the possibility of accepting book reviews of recent publications related to General and Digestive Surgery.